RayanaAI
Account
MRK
HOLD / NEUTRALMeanRev
Composite
53.30
Technical
82.90
Fundamental
43.50
Rank
—
Price
135.17
Hurst
0.37
As of
Aug 19, 2026
Daily
Merck & Co., Inc.
HealthcareDrug Manufacturers - General

Merck & Co., Inc. is a global pharmaceutical and healthcare company that develops and markets human medicines for oncology, infectious disease, vaccines, and other therapeutic areas, along with veterinary pharmaceuticals and animal health solutions across livestock and companion animal segments. The company operates through partnerships and licensing agreements with various biotech and pharmaceutical firms to expand its portfolio of cancer treatments, immunotherapies, and other drug candidates. Founded in 1891 and headquartered in New Jersey, Merck operates worldwide across human health, animal health, and healthcare services.

Market cap
$368.9B
P/E (trailing)
151.03
P/E (forward)
16.46
PEG ratio
2.82
Dividend yield
227.00%
Beta
0.22
52w range
82.01 – 156.92
Return on equity
—
Profit margin
+3.64%
Revenue growth
+4.70%
Earnings growth
-12.00%
Price history

1Y: 149.52 (+79.0%) · range 80.14–155.53

Cycle position
56/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 12 · NOT READY · exit proximity 0

Conviction
34/ 100 · maturity 86%
VScore.3634
Buildup.2155
EMA entry setup.2712
Fundamentals.1644
Volume profile
POC
147.16
Price vs POC
+1.6%
Overhead supply
10%
Runway
+0.3%

Value area 123.45–156.00 · 10% of 120d volume overhead · clean runway

Contributing sources
SourceScoreLast seen
earnings-surprise
0.967
Oct 30, 2026
trend-signal
0.048
Oct 15, 2026
trader-sentiment
0.040
Oct 26, 2026
Forward returns
HorizonReturnMFEState
20d-3.08%-1.76%2/20d
40d-3.08%-1.76%2/40d